---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-036929"
form_type: "8-K"
ticker: "SNWV"
cik: "0001417663"
company_name: "SANUWAVE Health, Inc."
filed_at: "2024-08-13T23:59:59+00:00"
generated_at: "2026-05-31T09:39:19.655583+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# SANUWAVE Q2 revenue $7.2M (+53% YoY); guides Q3 growth 65-75%

## Summary
- Q2 revenue $7.2M, up 53% YoY; 72 UltraMist systems sold vs 49 in Q2 2023.
- GAAP operating income $2.0M; net income $6.6M vs loss $7.3M YoY.
- Adjusted EBITDA $1.5M vs $171K YoY; year-to-date $1.4M vs -$1.6M.
- Q3 2024 revenue guidance $8-8.5M (65-75% growth); gross margin mid 70s.
- Reverse stock split approved, note/warrant exchange fully subscribed to simplify cap structure.

## SEC filing metadata
- accession: 0001140361-24-036929
- form_type: 8-K
- ticker: SNWV
- cik: 0001417663
- company_name: SANUWAVE Health, Inc.
- filed_at: 2024-08-13T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417663/000114036124036929/0001140361-24-036929-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417663/000114036124036929/ef20033924_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-036929
- JSON: https://secwatch.observer/filing/0001140361-24-036929.json
- Plain text: https://secwatch.observer/filing/0001140361-24-036929.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.